Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2023-07-10 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-10 English
Appointment
Regulatory Filings Classification · 95% confidence The document is extremely short (234 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. It does not fit any specific report category and appears to be a regulatory or compliance-related filing with minimal content. According to the rules, such minimal documents with no report content should be classified as Regulatory Filings (RNS).
2023-07-07 English
Resignation
Regulatory Filings Classification · 100% confidence The document is extremely short (221 characters) and contains no substantive financial data, report content, or detailed information. It only includes a digital signature and a placeholder for a picture. There is no indication of any report, announcement, or detailed filing. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings without substantive content.
2023-07-07 English
Board Meeting — BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Jul-2023 to consider Fund raising.
Regulatory Filings
2023-07-03 English
Board Meeting — Fund Raising
Regulatory Filings Classification · 100% confidence The document text is extremely short (88 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed filing. Given the lack of content, this document best fits the fallback category for miscellaneous filings or certifications, which is Regulatory Filings (RNS).
2023-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is extremely short (356 characters) and contains only a digital signature with a date, without any substantive financial data, report content, or detailed information. There is no indication of a full report, announcement, or detailed filing. It appears to be a certification or attestation by an officer. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2023-06-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.